TRAVATAN 0.004% travoprost 40 microgram/mL eye drop solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

travatan 0.004% travoprost 40 microgram/ml eye drop solution bottle

novartis pharmaceuticals australia pty ltd - travoprost, quantity: 40 microgram/ml - eye drops, solution - excipient ingredients: boric acid; ethoxylated hydrogenated castor oil; polyquaternium-1; sodium hydroxide; mannitol; hydrochloric acid; propylene glycol; purified water; sodium chloride - travatan eye drops are indicated to decrease elevated intraocular pressure in: - ocular hypertension. - open-angle glaucoma. travatan eye drops may be used: - as first line monotherapy. - as adjunctive therapy.

Travoprost Sandoz 40 micrograms/ml Eye drops, solution Ireland - English - HPRA (Health Products Regulatory Authority)

travoprost sandoz 40 micrograms/ml eye drops, solution

rowex ltd - travopost - eye drops, solution - 40 microgram(s)/millilitre - prostaglandin analogues1); travoprost

DUOTRAV travoprost 0.004% and timolol 0.5% (as maleate) eye drop solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

duotrav travoprost 0.004% and timolol 0.5% (as maleate) eye drop solution bottle

novartis pharmaceuticals australia pty ltd - travoprost, quantity: 40 microgram/ml; timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: ethoxylated hydrogenated castor oil; sodium hydroxide; propylene glycol; hydrochloric acid; sodium chloride; mannitol; boric acid; purified water; polyquaternium-1 - duotrav is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension for whom single agent therapy provides insufficient intraocular pressure reduction.

APO-TRAVOPROST/TIMOLOL 0.04/5 travoprost 40 micrograms/mL and timolol 5 mg/mL eye drops bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-travoprost/timolol 0.04/5 travoprost 40 micrograms/ml and timolol 5 mg/ml eye drops bottle

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); travoprost, quantity: 40 microgram/ml - eye drops - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium hydroxide; propylene glycol; mannitol; peg-40 hydrogenated castor oil; polyquaternium-1; boric acid - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension for whom single agent therapy provides insufficient intraocular pressure reduction.

BONDULC 40 Microgram/ML Eye Drops Solution Ireland - English - HPRA (Health Products Regulatory Authority)

bondulc 40 microgram/ml eye drops solution

actavis group ptc ehf - travoprost - eye drops solution - 40 microgram/ml - prostaglandin analogues

Bondulc 40 micrograms/ml eye drops, solution Malta - English - Medicines Authority

bondulc 40 micrograms/ml eye drops, solution

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - travoprost - eye drops, solution - travoprost 40 µg/ml - ophthalmologicals

Travoprost 40mcg/ml eye drops solution Malta - English - Medicines Authority

travoprost 40mcg/ml eye drops solution

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - travoprost - eye drops, solution - travoprost 40 µg - ophthalmologicals

Travoprost ratiopharm 40 microgram/ml, oogdruppels, oplossing Netherlands - English - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

travoprost ratiopharm 40 microgram/ml, oogdruppels, oplossing

Travoprost Teva 40 microgram/ml, oogdruppels, benzalkoniumchloridevrije oplossing Netherlands - English - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

travoprost teva 40 microgram/ml, oogdruppels, benzalkoniumchloridevrije oplossing

TRAVOPROST OPHTHALMIC SOLUTION 0.004%- travoprost solution United States - English - NLM (National Library of Medicine)

travoprost ophthalmic solution 0.004%- travoprost solution

par pharmaceutical, inc. - travoprost (unii: wj68r08kx9) (travoprost - unii:wj68r08kx9) - travoprost 0.04 mg in 1 ml - travoprost ophthalmic solution usp, 0.004% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. none pregnancy category c teratogenic effects: travoprost was teratogenic in rats, at an intravenous (iv) dose up to 10 mcg/kg/day (250 times the maximal recommended human ocular dose (mrhod), evidenced by an increase in the incidence of skeletal malformations as well as external and visceral malformations, such as fused sternebrae, domed head and hydrocephaly. travoprost was not teratogenic in rats at iv doses up to 3 mcg/kg/day (75 times the mrhod), or in mice at subcutaneous doses up to 1 mcg/kg/day (25 times the mrhod). travoprost produced an increase in post-implantation losses and a decrease in fetal viability in rats at iv doses >3 mcg/kg/day (75 times the mrhod) and in mice at subcutaneous doses >0.3 mcg/kg/day (7.5 times the mrhod). in the offspring of female rats that received travoprost subcutaneously from day 7 of pregnancy to lacta